Overview

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy and safety of cholinesterase inhibitor (donepezil hydrochloride) Aricept in patients with vascular dementia (VaD).
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
Eisai Co., Ltd.
Treatments:
Donepezil